Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Indocyanine green + isosulfan blue is a combination of two dyes used primarily for sentinel lymph node mapping and biopsy, especially in breast cancer and gynecologic oncology. Indocyanine green (ICG) is a fluorescent dye detected by near-infrared imaging, while isosulfan blue provides visual color contrast during surgery. The combination enhances the detection rate of sentinel lymph nodes compared to either agent alone, with studies showing improved sensitivity and reduced false negative rates when both are used together. ICG offers advantages such as real-time visualization, fewer allergic reactions compared to traditional blue dyes, and cost-effectiveness. Isosulfan blue has been widely used but can cause persistent skin staining or rare allergic reactions. This dual-dye approach allows surgeons to maximize the accuracy of lymphatic mapping in oncologic surgeries[1][3][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on indocyanine green + isosulfan blue.